Turning Point Brands Posts $151.1M in Q3 Sales
TPB sits 26% above its 52-week low of $54.17.
Summary
Turning Point Brands reported third-quarter sales of $151.1 million, up from the $143 million it posted in Q2 and above the IBES estimate of USD 146.7 million. Earnings came in at 19 cents per share, or 41 cents on an adjusted basis. Within the quarter, Stoker's sales rose 52% while Zig-Zag sales fell 15.5%. The company also reaffirmed FY2026 guidance: Modern Oral gross sales of $330-$350M, net sales of $260-$270M, and Adjusted EBITDA of $70-$80M. The sequential gain matters because Q2 operating income fell 37% and net income dropped 75% as heavy spending on modern oral products squeezed margins — the top line is holding up even as profitability was under pressure. The report lands just weeks after CEO Graham Purdy resigned for personal reasons and Executive Chairman David Glazek took over on October 1, so this is the first quarterly print under new leadership.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — TPB reaffirmed FY2026 guidance: Modern Oral gross sales $330-$350M, net sales $260-$270M, and Adjusted EBITDA $70-$80M.
At the time of this announcement, TPB was trading at $68.40 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $54.17 to $146.90. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.